Background: Androgenetic alopecia (AGA) is the most common cause of hair loss
affecting both men and women. There are many conflicting results about the relationship
between AGA and metabolic syndrome, (MetS) and the pathogenesis of the
metabolic disorders in AGA patients is not completely elucidated.
Aims: Evaluation of the prevalence of MetS and the possible role of RANTES in
pathogenesis of the MS among AGA patients.
Methods: A total of 160 subjects were enrolled in this work; included 100 patients
clinically diagnosed with AGA and 60 apparently healthy control subjects. They were
evaluated for MS components according to National Cholesterol Education Program
(NCEP) adult treatment panel 3 (ATP3) and measurement of serum RANTES level
using ELISA kits.
Results: Metabolic syndrome was present in 30.0% of AGA patients and in 10.0%
of the control group (P = .038), Studied AGA patients showed significantly higher
serum RANTES when compared to control group (P value < .001). Moreover, serum
RANTES levels were significantly positively correlated with BMI, FBG, TC, and LDL-c
levels in AGA patients with MetS.
Conclusion: Metabolic syndrome components were prevalent among AGA patients.
Serum RANTES level was significantly higher in all AGA patients and specifically in
those with MS as it was significantly positively correlated with some MetS components
which reflects its possible role in pathogenesis of MetS in AGA patients.